Skip to content
Review Open access

Advances in Injectable miRNA-Loaded Nanocomposite Hydrogel Systems for Cartilage Repair in KOA

Sep 2026 · International Journal of Nanomedicine · Vol 21, pp. 1-27 · 0 citations · 190 references
Medicine

TL;DR

This review systematically summarizes the design strategies, functional modifications and repair mechanisms of injectable miRNA-nanocomposite hydrogel systems, aiming to deepen mechanistic understanding, provide theoretical evidence for translational research, and promote the development of precise and individualized targeted therapies for KOA.

Abstract

Abstract Knee osteoarthritis (KOA) is a common degenerative joint disease characterized by irreversible cartilage injury, progressive tissue degeneration and compromised joint function. Conventional clinical treatments merely relieve symptoms rather than fundamentally repair damaged cartilage. As an innovative and promising therapeutic strategy, microRNA (miRNA)-based gene therapy modulates key pathogenic signaling pathways to improve core KOA pathological changes, including chondrocyte senescence, ECM degradation, synovial inflammation and aberrant subchondral bone remodeling. Nevertheless, the clinical application of bare miRNAs is greatly constrained by intra-articular biological barriers. Once delivered into the knee joint cavity, unprotected miRNAs are readily degraded by endogenous nucleases within synovial fluid, accompanied by off-target diffusion, undesired local inflammatory reactions, and rapid in-vivo clearance. Repeated injections are thus required to maintain effective drug concentration, which inevitably causes additional trauma to joint tissues and further compromises therapeutic performance. Injectable miRNA-nanocomposite hydrogel systems organically combine gene therapy, nanotechnology and biomaterial engineering, enabling localized intra-articular delivery, long-term sustained-release behaviour and lesion-oriented cartilage repair. Such biomaterial platforms are capable of remodelling the disordered intra-articular immune microenvironment and restoring subchondral bone homeostasis, so as to mitigate KOA-derived pathological lesions. Notwithstanding these promising advances, existing hydrogel formulations still face considerable bottlenecks in mechanical adaptability, cartilage-barrier penetration performance and long-term biosafety, which constitute major obstacles toward clinical translation. This review systematically summarizes the design strategies, functional modifications and repair mechanisms of these hydrogel systems, aiming to deepen mechanistic understanding, provide theoretical evidence for translational research, and promote the development of precise and individualized targeted therapies for KOA.

Read PDF

Similar papers

Review Open access Aug 2026

Nanoimmunomodulation for cartilage repair in osteoarthritis: reprogramming the inflammatory joint microenvironment

Osteoarthritis is a whole-joint disease characterized by persistent inflammation, immune dysregulation, oxidative stress, cellular senescence, and impaired cartilage repair. Current treatments remain largely symptomatic, underscoring the need for disease-modifying strategies that can reshape the pathological joint micr...

Han-Ning Wang, Fei Wang, Si-Jia Han et al. · 0 citations
Review Open access Aug 2026

Biologic and regenerative strategies for osteoarthritis: advances in MSC, exosome, and PRP based therapies

Biologic and regenerative interventions represent promising avenues for advancing cartilage repair and improving clinical outcomes in patients with osteoarthritis, and current evidence indicates that these therapies exert their effects through modulation of inflammatory pathways, enhancement of extracellular matrix syn...

Hai-Yuan Yue, Ahmad Alhaskawi, S. Ezzi et al. · 0 citations
Review Open access Sep 2026

Therapeutic potential of natural polymer-based microgels for cartilage regeneration with implications for osteoarthritis.

Articular cartilage has a limited intrinsic capacity for self-repair because of its avascular, aneural, and alymphatic nature, making cartilage repair a major clinical challenge. This limitation is particularly important in osteoarthritis (OA), where cartilage loss occurs within a complex whole-joint pathological envir...

Zahra Ghanavati, M. Farokhi, Fatemeh Koeini et al. · 0 citations
Open access Sep 2026

Cartilage-targeting engineered probiotic bacterial extracellular vesicles treat osteoarthritis through modulation of matrix homeostasis

Reversing extracellular matrix (ECM) metabolic dysregulation to facilitate cartilage repair represents a key therapeutic strategy for osteoarthritis (OA) treatment. Owing to the avascular nature of joint structures, intra-articular injection is a commonly used clinical administration route. However, the current drug re...

Lu-Yu Niu, Wan-Zhuo Chen, Tong Liu et al. · 0 citations
Review Open access Sep 2026

Hydrogel microspheres for osteoarthritis treatment: Fabrication strategies, smart responsiveness, and multimodal therapies

This review summarizes various therapeutic strategies supported by hydrogel microspheres, including the precise controlled release of small-molecule drugs, the regulation of endogenous stem cell recruitment and directed differentiation, the targeted delivery of gene therapy drugs, and synergistic treatment modalities.

Zhuo-Xuan Song, Xin-Yu Song, Rui Zhao et al. · 0 citations
Aug 2026

A scRNA-seq-guided gelsolin-functionalized gelatin methacryloyl platform integrating structural support and immunomodulation for osteoarthritis repair.

Osteoarthritis (OA) is a debilitating degenerative joint disease characterized by the irreversible breakdown of articular cartilage and chronic synovial inflammation. Current clinical interventions are primarily palliative, failing to address the dual challenges of structural degradation and the hostile, inflammatory m...

X.-V. Huang, Shou-Jie Wang, Gen-Ying Zhuang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.